Skip to main content
. 2004 Sep 1;5:120. doi: 10.1186/1471-2105-5-120

Table 6.

Two-SNP interactions among the 10 selected SNPs (P-value < 0.05 and ECV2 < 0.5)

SNP 1 SNP 1 genotype SNP 2 Pa Pb Pc Pb × Pc Pa/(Pb × Pc)
C3 (4896 C/T) TT C3 (1692 G/A) 0.01461 0.7205 0.6993 0.5038 0.0290
CysLT2 (2534 A/G) AG+GG IL-4Rα (148 G/A) 0.00030 0.5664 0.0155 0.0088 0.0344
C3 (1692 G/A) AA C3 (4896 C/T) 0.02858 0.6993 0.7205 0.5038 0.0567
C3 (912 G/A) GG C3 (4896 C/T) 0.02345 0.5020 0.7205 0.3617 0.0648
C3 (4896 C/T) TT C3 (912 G/A) 0.03073 0.7205 0.5020 0.3617 0.0850
C3 (1692 G/A) GA CysLT2 (2534 A/G) 0.04917 0.6993 0.5664 0.3961 0.1241
STAT6 (2964 G/A) GG+GA IL-10 (-571 C/A) 0.01752 0.7881 0.1074 0.0846 0.2070
C3 (4896 C/T) TT IL-4Rα (148 G/A) 0.00271 0.7205 0.0155 0.0112 0.2426
C3 (912 G/A) GG IL-4Rα (148 G/A) 0.00345 0.5020 0.0155 0.0078 0.4442
IL-4 (-590 C/T) CT+TT IL-4Rα (148 G/A) 0.00689 0.9085 0.0155 0.0141 0.4896

aP-value of combination of SNP 2 with genotype consisting of SNP 1. In this case, D.F. of SNP 2 is identical to that of Table 1.

bP-value of SNP 1 calculated alone.

cP-value of SNP 2 calculated alone.

aP/(bP × cP) represents effective combination value (ECV2).

HHS Vulnerability Disclosure